{"id":356331,"date":"2025-08-29T06:15:55","date_gmt":"2025-08-29T06:15:55","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-vaxcyte\/"},"modified":"2025-08-29T06:15:55","modified_gmt":"2025-08-29T06:15:55","slug":"how-to-buy-vaxcyte","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-356331","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Vaxcyte, Inc. (PCVX) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Vaxcyte, Inc. (PCVX)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Vaxcyte, Inc. (PCVX) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Vaxcyte, Inc. (PCVX)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u00e1nh gi\u00e1 r\u1ee7i ro v\u00e0 chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 cho c\u00f4ng ty vaccine s\u00e1ng t\u1ea1o n\u00e0y.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u00e1nh gi\u00e1 r\u1ee7i ro v\u00e0 chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 cho c\u00f4ng ty vaccine s\u00e1ng t\u1ea1o n\u00e0y."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o t\u01b0\u01a1ng lai c\u1ee7a c\u00f4ng ngh\u1ec7 vaccine? Vaxcyte, Inc. l\u00e0 m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn nh\u1ea5t trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc hi\u1ec7n nay. C\u00f4ng ty giai \u0111o\u1ea1n l\u00e2m s\u00e0ng n\u00e0y \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta ch\u1ed1ng l\u1ea1i c\u00e1c b\u1ec7nh nhi\u1ec5m khu\u1ea9n v\u1edbi c\u00e1c n\u1ec1n t\u1ea3ng vaccine ti\u00ean ti\u1ebfn. Ch\u00fang t\u00f4i s\u1ebd ph\u00e2n t\u00edch t\u1ea5t c\u1ea3 nh\u1eefng g\u00ec b\u1ea1n c\u1ea7n bi\u1ebft v\u1ec1 vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu PCVX \u2014 t\u1eeb hi\u1ec7u su\u1ea5t hi\u1ec7n t\u1ea1i \u0111\u1ebfn ti\u1ec1m n\u0103ng d\u00e0i h\u1ea1n.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o t\u01b0\u01a1ng lai c\u1ee7a c\u00f4ng ngh\u1ec7 vaccine? Vaxcyte, Inc. l\u00e0 m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn nh\u1ea5t trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc hi\u1ec7n nay. C\u00f4ng ty giai \u0111o\u1ea1n l\u00e2m s\u00e0ng n\u00e0y \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta ch\u1ed1ng l\u1ea1i c\u00e1c b\u1ec7nh nhi\u1ec5m khu\u1ea9n v\u1edbi c\u00e1c n\u1ec1n t\u1ea3ng vaccine ti\u00ean ti\u1ebfn. Ch\u00fang t\u00f4i s\u1ebd ph\u00e2n t\u00edch t\u1ea5t c\u1ea3 nh\u1eefng g\u00ec b\u1ea1n c\u1ea7n bi\u1ebft v\u1ec1 vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu PCVX \u2014 t\u1eeb hi\u1ec7u su\u1ea5t hi\u1ec7n t\u1ea1i \u0111\u1ebfn ti\u1ec1m n\u0103ng d\u00e0i h\u1ea1n."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Vaxcyte: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 29 th\u00e1ng 8 n\u0103m 2025, Vaxcyte, Inc. (PCVX) giao d\u1ecbch \u1edf m\u1ee9c <strong>30,55 USD<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>4 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u2014 \u0111\u00f3 l\u00e0 khi Vaxcyte c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o n\u00e0y th\u01b0\u1eddng k\u00edch ho\u1ea1t nh\u1eefng bi\u1ebfn \u0111\u1ed9ng gi\u00e1 l\u1edbn.<\/p> <h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng Thu Nh\u1eadp<\/h3> <p>B\u00e1o c\u00e1o thu nh\u1eadp ng\u00e0y 6 th\u00e1ng 8 n\u0103m 2025 cho th\u1ea5y t\u1ea1i sao th\u1eddi \u0111i\u1ec3m l\u1ea1i quan tr\u1ecdng. Vaxcyte b\u00e1o c\u00e1o l\u1ed7 r\u00f2ng 166,6 tri\u1ec7u USD m\u00e0 kh\u00f4ng c\u00f3 doanh thu, tuy nhi\u00ean c\u1ed5 phi\u1ebfu v\u1eabn gi\u1eef \u1ed5n \u0111\u1ecbnh t\u01b0\u01a1ng \u0111\u1ed1i v\u00ec nh\u00e0 \u0111\u1ea7u t\u01b0 \u0111\u00e3 k\u1ef3 v\u1ecdng \u0111i\u1ec1u n\u00e0y t\u1eeb m\u1ed9t c\u00f4ng ty giai \u0111o\u1ea1n l\u00e2m s\u00e0ng <a href=\"https:\/\/www.stocktitan.net\/news\/PCVX\/vaxcyte-reports-second-quarter-2025-financial-results-and-provides-9l3y1y5unk80.html\">StockTitan<\/a>. C\u00e2u chuy\u1ec7n th\u1ef1c s\u1ef1 l\u00e0 ti\u1ebfn tri\u1ec3n trong ch\u01b0\u01a1ng tr\u00ecnh VAX-31 c\u1ee7a h\u1ecd \u0111ang ti\u1ebfn t\u1edbi th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 3.<\/p> <p>D\u01b0\u1edbi \u0111\u00e2y l\u00e0 c\u00e1ch c\u00e1c b\u00e1o c\u00e1o thu nh\u1eadp g\u1ea7n \u0111\u00e2y \u0111\u00e3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn c\u1ed5 phi\u1ebfu:<\/p> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><\/tr> <\/thead> <tbody> <tr><td>6 th\u00e1ng 8, 2025<\/td><td>Thu nh\u1eadp Q2<\/td><td>31,20 USD<\/td><td>-2,1% (\u1ed5n \u0111\u1ecbnh)<\/td><\/tr> <tr><td>23 th\u00e1ng 5, 2025<\/td><td>K\u1ebft qu\u1ea3 Giai \u0111o\u1ea1n II<\/td><td>69,46 USD<\/td><td>-45% (m\u1ed9t ng\u00e0y)<\/td><\/tr> <tr><td>28 th\u00e1ng 3, 2025<\/td><td>D\u1eef li\u1ec7u th\u1eed nghi\u1ec7m<\/td><td>72,10 USD<\/td><td>-4,2% (tr\u01b0\u1edbc b\u00e1n th\u00e1o)<\/td><\/tr> <\/tbody> <\/table> <p>\u0110\u1ee3t s\u1ee5t gi\u1ea3m th\u00e1ng 5 \u0111\u00e3 d\u1ea1y ch\u00fang ta m\u1ed9t b\u00e0i h\u1ecdc \u0111au \u0111\u1edbn: ngay c\u1ea3 khi th\u1eed nghi\u1ec7m v\u1ec1 m\u1eb7t k\u1ef9 thu\u1eadt \u0111\u1ea1t \u0111\u01b0\u1ee3c c\u00e1c \u0111i\u1ec3m cu\u1ed1i, k\u1ef3 v\u1ecdng c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00f3 th\u1ec3 g\u00e2y ra nh\u1eefng \u0111\u1ee3t b\u00e1n th\u00e1o th\u1ea3m kh\u1ed1c <a href=\"https:\/\/www.clinicaltrialsarena.com\/news\/vaxcyte-ipd-vaccine-phase-ii-infant-stock-sinks\/\">Clinical Trials Arena<\/a>.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: C\u1ea3m Gi\u00e1c T\u00e0u L\u01b0\u1ee3n Si\u00eau T\u1ed1c<\/h2> <p>C\u1ed5 phi\u1ebfu Vaxcyte \u0111\u00e3 tr\u1ea3i qua s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ef1c \u0111oan trong 6 th\u00e1ng qua, gi\u1ea3m kho\u1ea3ng <strong>61%<\/strong> t\u1eeb \u0111\u1ec9nh th\u00e1ng 1:<\/p> <p><strong>Th\u00e1ng 1 n\u0103m 2025<\/strong>: 93,77 USD (\u0111\u1ec9nh l\u1ea1c quan)<br\/> <strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 69,46 USD (tr\u01b0\u1edbc k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m)<br\/> <strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 32,54 USD (s\u1ee5t gi\u1ea3m sau th\u1eed nghi\u1ec7m)<br\/> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 30,55 USD (\u1ed5n \u0111\u1ecbnh hi\u1ec7n t\u1ea1i)<\/p> <p>S\u1ef1 s\u1ee5t gi\u1ea3m m\u1ea1nh n\u00e0y ph\u1ea3n \u00e1nh t\u00ednh ch\u1ea5t r\u1ee7i ro cao c\u1ee7a \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng. C\u1ed5 phi\u1ebfu \u0111\u00e3 t\u00ecm th\u1ea5y s\u1ef1 \u1ed5n \u0111\u1ecbnh quanh m\u1ee9c 30 USD, g\u1ee3i \u00fd \u0111\u00e2y c\u00f3 th\u1ec3 l\u00e0 m\u1ee9c h\u1ed7 tr\u1ee3 <a href=\"https:\/\/stockanalysis.com\/stocks\/pcvx\/\">StockAnalysis<\/a>.<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p> <p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 40-50 USD (t\u0103ng nh\u1edd kh\u1edfi \u0111\u1ea7u Giai \u0111o\u1ea1n 3) \u2192 <strong>MUA<\/strong><br\/> <strong>2026<\/strong>: 90-110 USD (ti\u1ec1m n\u0103ng d\u1eef li\u1ec7u t\u1ea1m th\u1eddi t\u00edch c\u1ef1c)<br\/> <strong>2028<\/strong>: 120-150 USD (giai \u0111o\u1ea1n n\u1ed9p h\u1ed3 s\u01a1 ph\u00ea duy\u1ec7t)<br\/> <strong>2030<\/strong>: 180-220 USD (ti\u1ec1m n\u0103ng th\u01b0\u01a1ng m\u1ea1i h\u00f3a)<\/p> <p>C\u00e1c nh\u00e0 ph\u00e2n t\u00edch duy tr\u00ec s\u1ef1 l\u1ea1c quan m\u1ea1nh m\u1ebd v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh l\u00e0 <strong>136,50 USD<\/strong> \u2014 t\u01b0\u01a1ng \u0111\u01b0\u01a1ng m\u1ee9c t\u0103ng 343% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/PCVX\/forecast\/\">MarketBeat<\/a>. M\u01b0\u1eddi tr\u00ean m\u01b0\u1eddi m\u1ed9t nh\u00e0 ph\u00e2n t\u00edch \u0111\u00e1nh gi\u00e1 \u0111\u00e2y l\u00e0 \"Mua\" ho\u1eb7c \"Mua M\u1ea1nh\".<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3> <ul> <li><strong>R\u1ee7i ro th\u1ea5t b\u1ea1i l\u00e2m s\u00e0ng<\/strong>: \u0110\u1ee3t s\u1ee5t gi\u1ea3m 45% th\u00e1ng 5 n\u0103m 2025 cho th\u1ea5y t\u00e1c \u0111\u1ed9ng nghi\u00eam tr\u1ecdng c\u1ee7a k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m m\u1ed9t ph\u1ea7n<\/li> <li><strong>Kh\u00f4ng ch\u1eafc ch\u1eafn v\u1ec1 quy \u0111\u1ecbnh<\/strong>: Vi\u1ec7c quan ch\u1ee9c FDA t\u1eeb ch\u1ee9c t\u1ea1o ra c\u00e1c m\u1ed1c th\u1eddi gian kh\u00f3 \u0111o\u00e1n<\/li> <li><strong>Ti\u00eau ti\u1ec1n m\u1eb7t<\/strong>: L\u1ed7 166,6 tri\u1ec7u USD m\u1ed7i qu\u00fd m\u00e0 ch\u01b0a c\u00f3 doanh thu<\/li> <li><strong>C\u1ea1nh tranh<\/strong>: Vaccine c\u1ee7a Pfizer \u0111\u00e3 chi\u1ebfm l\u0129nh th\u1ecb tr\u01b0\u1eddng<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3> <ul> <li><strong>Ti\u1ebfn tri\u1ec3n Giai \u0111o\u1ea1n 3<\/strong>: VAX-31 \u0111\u01b0\u1ee3c ph\u00e9p ti\u1ebfn h\u00e0nh th\u1eed nghi\u1ec7m then ch\u1ed1t b\u1eaft \u0111\u1ea7u qu\u00fd 4 n\u0103m 2025<\/li> <li><strong>Ch\u1ec9 \u0111\u1ecbnh \u0111\u1ed9t ph\u00e1<\/strong>: FDA m\u1edf r\u1ed9ng ch\u1ec9 \u0111\u1ecbnh n\u00e0y bao g\u1ed3m ph\u00f2ng ng\u1eeba vi\u00eam ph\u1ed5i<\/li> <li><strong>V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t m\u1ea1nh<\/strong>: 2,8 t\u1ef7 USD k\u00e9o d\u00e0i th\u1eddi gian ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn gi\u1eefa n\u0103m 2028<\/li> <li><strong>T\u1ef1 tin c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/strong>: 93% khuy\u1ebfn ngh\u1ecb mua v\u1edbi m\u1ee5c ti\u00eau t\u0103ng gi\u00e1 l\u1edbn<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>Trung b\u00ecnh gi\u00e1 theo \u0111\u00f4 la<\/strong>: \u0110\u1ea7u t\u01b0 s\u1ed1 ti\u1ec1n nh\u1ecf \u0111\u1ec1u \u0111\u1eb7n thay v\u00ec c\u1ed1 g\u1eafng b\u1eaft th\u1eddi \u0111i\u1ec3m th\u1ecb tr\u01b0\u1eddng<\/li> <li><strong>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7<\/strong>: B\u1ea3o v\u1ec7 b\u1ea1n kh\u1ecfi \u0111\u1ee3t gi\u1ea3m 45% trong m\u1ed9t ng\u00e0y kh\u00e1c<\/li> <li><strong>Ch\u00fa \u00fd ng\u00e0y 4 th\u00e1ng 11<\/strong>: B\u00e1o c\u00e1o thu nh\u1eadp c\u00f3 th\u1ec3 l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn ti\u1ebfp theo<\/li> <li><strong>\u0110a d\u1ea1ng h\u00f3a<\/strong>: Kh\u00f4ng bao gi\u1edd \u0111\u1ea7u t\u01b0 qu\u00e1 5% danh m\u1ee5c v\u00e0o m\u1ed9t c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li> <\/ol> <p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: \"Giao d\u1ecbch PCVX gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba \u2014 ti\u1ec1m n\u0103ng tuy\u1ec7t v\u1eddi nh\u01b0ng d\u1ec5 thay \u0111\u1ed5i t\u00e2m tr\u1ea1ng khi th\u00ed nghi\u1ec7m kh\u00f4ng nh\u01b0 k\u1ebf ho\u1ea1ch!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Vaxcyte, Inc. (PCVX) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 c\u1ed5 phi\u1ebfu NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n t\u1ea5t x\u00e1c minh<\/td><td>Chu\u1ea9n b\u1ecb gi\u1ea5y t\u1edd t\u00f9y th\u00e2n \u0111\u1ec3 m\u1edf t\u00e0i kho\u1ea3n nhanh ch\u00f3ng<\/td><\/tr> <tr><td>3<\/td><td>N\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td><\/tr> <tr><td>4<\/td><td>T\u00ecm ki\u1ebfm \"PCVX\"<\/td><td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ecm \"Vaxcyte\"<\/td><\/tr> <tr><td>5<\/td><td>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n<\/td><td>\u0110\u1eb7t gi\u00e1 mua t\u1ed1i \u0111a \u0111\u1ec3 tr\u00e1nh tr\u1ea3 qu\u00e1 cao<\/td><\/tr> <tr><td>6<\/td><td>Ki\u1ec3m tra chi ti\u1ebft l\u1ec7nh<\/td><td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng \u2014 n\u00ean d\u01b0\u1edbi 1%<\/td><\/tr> <tr><td>7<\/td><td>X\u00e1c nh\u1eadn mua<\/td><td>B\u1ea1n \u0111\u00e3 s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n c\u00f4ng ty vaccine s\u00e1ng t\u1ea1o<\/td><\/tr> <tr><td>8<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/td><td>Nh\u1eadn th\u00f4ng b\u00e1o khi c\u00f3 bi\u1ebfn \u0111\u1ed9ng gi\u00e1 l\u1edbn<\/td><\/tr> <tr><td>9<\/td><td>Theo d\u00f5i tin t\u1ee9c<\/td><td>Theo d\u00f5i c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 quy\u1ebft \u0111\u1ecbnh FDA<\/td><\/tr> <tr><td>10<\/td><td>\u0110\u00e1nh gi\u00e1 \u0111\u1ecbnh k\u1ef3<\/td><td>C\u00f4ng ngh\u1ec7 sinh h\u1ecdc c\u1ea7n theo d\u00f5i t\u00edch c\u1ef1c, kh\u00f4ng ph\u1ea3i mua r\u1ed3i qu\u00ean<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf khi giao d\u1ecbch c\u1ed5 phi\u1ebfu nh\u01b0 PCVX:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> \u2014 ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li> <li><strong>Quy tr\u00ecnh KYC 1 ph\u00fat<\/strong> \u2014 t\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch ngay<\/li> <li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> \u2014 t\u1eeb ti\u1ec1n \u0111i\u1ec7n t\u1eed \u0111\u1ebfn v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 th\u1ebb ng\u00e2n h\u00e0ng<\/li> <li><strong>C\u1ed5 phi\u1ebfu l\u1ebb c\u00f3 s\u1eb5n<\/strong> \u2014 mua ph\u1ea7n nh\u1ecf c\u1ee7a c\u00e1c c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n nh\u01b0 PCVX m\u00e0 kh\u00f4ng c\u1ea7n mua nguy\u00ean c\u1ed5 phi\u1ebfu<\/li> <\/ul> <p>N\u1ec1n t\u1ea3ng v\u1edbi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p n\u00e0y r\u1ea5t l\u00fd t\u01b0\u1edfng cho ng\u01b0\u1eddi m\u1edbi mu\u1ed1n ti\u1ebfp c\u1eadn c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u1ec1m n\u0103ng cao m\u00e0 kh\u00f4ng c\u1ea7n \u0111\u1ea7u t\u01b0 s\u1ed1 v\u1ed1n l\u1edbn.<\/p> <h2>\ud83c\udf0d Vaxcyte N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi Vaccine<\/h2> <p>Vaxcyte \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong c\u00f4ng ngh\u1ec7 vaccine th\u1ebf h\u1ec7 m\u1edbi. S\u1eed d\u1ee5ng n\u1ec1n t\u1ea3ng \u0111\u1ed9c quy\u1ec1n XpressCF\u2122, h\u1ecd \u0111ang ph\u00e1t tri\u1ec3n c\u00e1c vaccine li\u00ean h\u1ee3p c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta ph\u00f2ng ng\u1eeba c\u00e1c b\u1ec7nh nhi\u1ec5m khu\u1ea9n <a href=\"https:\/\/stockanalysis.com\/stocks\/pcvx\/company\/\">StockAnalysis<\/a>.<\/p> <p>\u1ee8ng vi\u00ean h\u00e0ng \u0111\u1ea7u c\u1ee7a c\u00f4ng ty, VAX-24, nh\u1eafm v\u00e0o 24 ch\u1ee7ng vi khu\u1ea9n ph\u1ebf c\u1ea7u, trong khi VAX-31 m\u1edf r\u1ed9ng l\u00ean 31 ch\u1ee7ng \u2014 c\u00f3 th\u1ec3 cung c\u1ea5p s\u1ef1 b\u1ea3o v\u1ec7 r\u1ed9ng h\u01a1n vaccine hi\u1ec7n c\u00f3. V\u1edbi 414 nh\u00e2n vi\u00ean v\u00e0 tr\u1ee5 s\u1edf t\u1ea1i San Carlos, California, Vaxcyte \u0111\u1ea1i di\u1ec7n cho s\u1ef1 \u0111\u1ed5i m\u1edbi c\u1ee7a n\u01b0\u1edbc M\u1ef9 \u1edf m\u1ee9c cao nh\u1ea5t.<\/p> <p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb<\/strong>: N\u0103m 2025, ch\u1ec9 \u0111\u1ecbnh \u0110i\u1ec1u Tr\u1ecb \u0110\u1ed9t Ph\u00e1 c\u1ee7a FDA d\u00e0nh cho Vaxcyte \u0111\u00e3 \u0111\u01b0\u1ee3c m\u1edf r\u1ed9ng bao g\u1ed3m ph\u00f2ng ng\u1eeba vi\u00eam ph\u1ed5i \u2014 m\u1ed9t th\u00e0nh t\u1ef1u quy \u0111\u1ecbnh hi\u1ebfm c\u00f3 l\u00e0m n\u1ed5i b\u1eadt t\u1ea7m quan tr\u1ecdng ti\u1ec1m n\u0103ng c\u1ee7a \u1ee9ng vi\u00ean vaccine VAX-31 <a href=\"https:\/\/www.stocktitan.net\/news\/PCVX\/vaxcyte-reports-second-quarter-2025-financial-results-and-provides-9l3y1y5unk80.html\">StockTitan<\/a>. \u0110i\u1ec1u n\u00e0y \u0111\u1eb7t h\u1ecd v\u00e0o nh\u00f3m tinh hoa trong s\u1ed1 c\u00e1c nh\u00e0 \u0111\u1ed5i m\u1edbi c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Vaxcyte: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 29 th\u00e1ng 8 n\u0103m 2025, Vaxcyte, Inc. (PCVX) giao d\u1ecbch \u1edf m\u1ee9c <strong>30,55 USD<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>4 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u2014 \u0111\u00f3 l\u00e0 khi Vaxcyte c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o n\u00e0y th\u01b0\u1eddng k\u00edch ho\u1ea1t nh\u1eefng bi\u1ebfn \u0111\u1ed9ng gi\u00e1 l\u1edbn.<\/p>\n<h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng Thu Nh\u1eadp<\/h3>\n<p>B\u00e1o c\u00e1o thu nh\u1eadp ng\u00e0y 6 th\u00e1ng 8 n\u0103m 2025 cho th\u1ea5y t\u1ea1i sao th\u1eddi \u0111i\u1ec3m l\u1ea1i quan tr\u1ecdng. Vaxcyte b\u00e1o c\u00e1o l\u1ed7 r\u00f2ng 166,6 tri\u1ec7u USD m\u00e0 kh\u00f4ng c\u00f3 doanh thu, tuy nhi\u00ean c\u1ed5 phi\u1ebfu v\u1eabn gi\u1eef \u1ed5n \u0111\u1ecbnh t\u01b0\u01a1ng \u0111\u1ed1i v\u00ec nh\u00e0 \u0111\u1ea7u t\u01b0 \u0111\u00e3 k\u1ef3 v\u1ecdng \u0111i\u1ec1u n\u00e0y t\u1eeb m\u1ed9t c\u00f4ng ty giai \u0111o\u1ea1n l\u00e2m s\u00e0ng <a href=\"https:\/\/www.stocktitan.net\/news\/PCVX\/vaxcyte-reports-second-quarter-2025-financial-results-and-provides-9l3y1y5unk80.html\">StockTitan<\/a>. C\u00e2u chuy\u1ec7n th\u1ef1c s\u1ef1 l\u00e0 ti\u1ebfn tri\u1ec3n trong ch\u01b0\u01a1ng tr\u00ecnh VAX-31 c\u1ee7a h\u1ecd \u0111ang ti\u1ebfn t\u1edbi th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 3.<\/p>\n<p>D\u01b0\u1edbi \u0111\u00e2y l\u00e0 c\u00e1ch c\u00e1c b\u00e1o c\u00e1o thu nh\u1eadp g\u1ea7n \u0111\u00e2y \u0111\u00e3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn c\u1ed5 phi\u1ebfu:<\/p>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>6 th\u00e1ng 8, 2025<\/td>\n<td>Thu nh\u1eadp Q2<\/td>\n<td>31,20 USD<\/td>\n<td>-2,1% (\u1ed5n \u0111\u1ecbnh)<\/td>\n<\/tr>\n<tr>\n<td>23 th\u00e1ng 5, 2025<\/td>\n<td>K\u1ebft qu\u1ea3 Giai \u0111o\u1ea1n II<\/td>\n<td>69,46 USD<\/td>\n<td>-45% (m\u1ed9t ng\u00e0y)<\/td>\n<\/tr>\n<tr>\n<td>28 th\u00e1ng 3, 2025<\/td>\n<td>D\u1eef li\u1ec7u th\u1eed nghi\u1ec7m<\/td>\n<td>72,10 USD<\/td>\n<td>-4,2% (tr\u01b0\u1edbc b\u00e1n th\u00e1o)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\u0110\u1ee3t s\u1ee5t gi\u1ea3m th\u00e1ng 5 \u0111\u00e3 d\u1ea1y ch\u00fang ta m\u1ed9t b\u00e0i h\u1ecdc \u0111au \u0111\u1edbn: ngay c\u1ea3 khi th\u1eed nghi\u1ec7m v\u1ec1 m\u1eb7t k\u1ef9 thu\u1eadt \u0111\u1ea1t \u0111\u01b0\u1ee3c c\u00e1c \u0111i\u1ec3m cu\u1ed1i, k\u1ef3 v\u1ecdng c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00f3 th\u1ec3 g\u00e2y ra nh\u1eefng \u0111\u1ee3t b\u00e1n th\u00e1o th\u1ea3m kh\u1ed1c <a href=\"https:\/\/www.clinicaltrialsarena.com\/news\/vaxcyte-ipd-vaccine-phase-ii-infant-stock-sinks\/\">Clinical Trials Arena<\/a>.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: C\u1ea3m Gi\u00e1c T\u00e0u L\u01b0\u1ee3n Si\u00eau T\u1ed1c<\/h2>\n<p>C\u1ed5 phi\u1ebfu Vaxcyte \u0111\u00e3 tr\u1ea3i qua s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ef1c \u0111oan trong 6 th\u00e1ng qua, gi\u1ea3m kho\u1ea3ng <strong>61%<\/strong> t\u1eeb \u0111\u1ec9nh th\u00e1ng 1:<\/p>\n<p><strong>Th\u00e1ng 1 n\u0103m 2025<\/strong>: 93,77 USD (\u0111\u1ec9nh l\u1ea1c quan)<br \/> <strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 69,46 USD (tr\u01b0\u1edbc k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m)<br \/> <strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 32,54 USD (s\u1ee5t gi\u1ea3m sau th\u1eed nghi\u1ec7m)<br \/> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 30,55 USD (\u1ed5n \u0111\u1ecbnh hi\u1ec7n t\u1ea1i)<\/p>\n<p>S\u1ef1 s\u1ee5t gi\u1ea3m m\u1ea1nh n\u00e0y ph\u1ea3n \u00e1nh t\u00ednh ch\u1ea5t r\u1ee7i ro cao c\u1ee7a \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng. C\u1ed5 phi\u1ebfu \u0111\u00e3 t\u00ecm th\u1ea5y s\u1ef1 \u1ed5n \u0111\u1ecbnh quanh m\u1ee9c 30 USD, g\u1ee3i \u00fd \u0111\u00e2y c\u00f3 th\u1ec3 l\u00e0 m\u1ee9c h\u1ed7 tr\u1ee3 <a href=\"https:\/\/stockanalysis.com\/stocks\/pcvx\/\">StockAnalysis<\/a>.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p>\n<p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 40-50 USD (t\u0103ng nh\u1edd kh\u1edfi \u0111\u1ea7u Giai \u0111o\u1ea1n 3) \u2192 <strong>MUA<\/strong><br \/> <strong>2026<\/strong>: 90-110 USD (ti\u1ec1m n\u0103ng d\u1eef li\u1ec7u t\u1ea1m th\u1eddi t\u00edch c\u1ef1c)<br \/> <strong>2028<\/strong>: 120-150 USD (giai \u0111o\u1ea1n n\u1ed9p h\u1ed3 s\u01a1 ph\u00ea duy\u1ec7t)<br \/> <strong>2030<\/strong>: 180-220 USD (ti\u1ec1m n\u0103ng th\u01b0\u01a1ng m\u1ea1i h\u00f3a)<\/p>\n<p>C\u00e1c nh\u00e0 ph\u00e2n t\u00edch duy tr\u00ec s\u1ef1 l\u1ea1c quan m\u1ea1nh m\u1ebd v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh l\u00e0 <strong>136,50 USD<\/strong> \u2014 t\u01b0\u01a1ng \u0111\u01b0\u01a1ng m\u1ee9c t\u0103ng 343% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/PCVX\/forecast\/\">MarketBeat<\/a>. M\u01b0\u1eddi tr\u00ean m\u01b0\u1eddi m\u1ed9t nh\u00e0 ph\u00e2n t\u00edch \u0111\u00e1nh gi\u00e1 \u0111\u00e2y l\u00e0 &#8220;Mua&#8221; ho\u1eb7c &#8220;Mua M\u1ea1nh&#8221;.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3>\n<ul>\n<li><strong>R\u1ee7i ro th\u1ea5t b\u1ea1i l\u00e2m s\u00e0ng<\/strong>: \u0110\u1ee3t s\u1ee5t gi\u1ea3m 45% th\u00e1ng 5 n\u0103m 2025 cho th\u1ea5y t\u00e1c \u0111\u1ed9ng nghi\u00eam tr\u1ecdng c\u1ee7a k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m m\u1ed9t ph\u1ea7n<\/li>\n<li><strong>Kh\u00f4ng ch\u1eafc ch\u1eafn v\u1ec1 quy \u0111\u1ecbnh<\/strong>: Vi\u1ec7c quan ch\u1ee9c FDA t\u1eeb ch\u1ee9c t\u1ea1o ra c\u00e1c m\u1ed1c th\u1eddi gian kh\u00f3 \u0111o\u00e1n<\/li>\n<li><strong>Ti\u00eau ti\u1ec1n m\u1eb7t<\/strong>: L\u1ed7 166,6 tri\u1ec7u USD m\u1ed7i qu\u00fd m\u00e0 ch\u01b0a c\u00f3 doanh thu<\/li>\n<li><strong>C\u1ea1nh tranh<\/strong>: Vaccine c\u1ee7a Pfizer \u0111\u00e3 chi\u1ebfm l\u0129nh th\u1ecb tr\u01b0\u1eddng<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>Ti\u1ebfn tri\u1ec3n Giai \u0111o\u1ea1n 3<\/strong>: VAX-31 \u0111\u01b0\u1ee3c ph\u00e9p ti\u1ebfn h\u00e0nh th\u1eed nghi\u1ec7m then ch\u1ed1t b\u1eaft \u0111\u1ea7u qu\u00fd 4 n\u0103m 2025<\/li>\n<li><strong>Ch\u1ec9 \u0111\u1ecbnh \u0111\u1ed9t ph\u00e1<\/strong>: FDA m\u1edf r\u1ed9ng ch\u1ec9 \u0111\u1ecbnh n\u00e0y bao g\u1ed3m ph\u00f2ng ng\u1eeba vi\u00eam ph\u1ed5i<\/li>\n<li><strong>V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t m\u1ea1nh<\/strong>: 2,8 t\u1ef7 USD k\u00e9o d\u00e0i th\u1eddi gian ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn gi\u1eefa n\u0103m 2028<\/li>\n<li><strong>T\u1ef1 tin c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/strong>: 93% khuy\u1ebfn ngh\u1ecb mua v\u1edbi m\u1ee5c ti\u00eau t\u0103ng gi\u00e1 l\u1edbn<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>Trung b\u00ecnh gi\u00e1 theo \u0111\u00f4 la<\/strong>: \u0110\u1ea7u t\u01b0 s\u1ed1 ti\u1ec1n nh\u1ecf \u0111\u1ec1u \u0111\u1eb7n thay v\u00ec c\u1ed1 g\u1eafng b\u1eaft th\u1eddi \u0111i\u1ec3m th\u1ecb tr\u01b0\u1eddng<\/li>\n<li><strong>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7<\/strong>: B\u1ea3o v\u1ec7 b\u1ea1n kh\u1ecfi \u0111\u1ee3t gi\u1ea3m 45% trong m\u1ed9t ng\u00e0y kh\u00e1c<\/li>\n<li><strong>Ch\u00fa \u00fd ng\u00e0y 4 th\u00e1ng 11<\/strong>: B\u00e1o c\u00e1o thu nh\u1eadp c\u00f3 th\u1ec3 l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn ti\u1ebfp theo<\/li>\n<li><strong>\u0110a d\u1ea1ng h\u00f3a<\/strong>: Kh\u00f4ng bao gi\u1edd \u0111\u1ea7u t\u01b0 qu\u00e1 5% danh m\u1ee5c v\u00e0o m\u1ed9t c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li>\n<\/ol>\n<p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: &#8220;Giao d\u1ecbch PCVX gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba \u2014 ti\u1ec1m n\u0103ng tuy\u1ec7t v\u1eddi nh\u01b0ng d\u1ec5 thay \u0111\u1ed5i t\u00e2m tr\u1ea1ng khi th\u00ed nghi\u1ec7m kh\u00f4ng nh\u01b0 k\u1ebf ho\u1ea1ch!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Vaxcyte, Inc. (PCVX) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 c\u1ed5 phi\u1ebfu NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t x\u00e1c minh<\/td>\n<td>Chu\u1ea9n b\u1ecb gi\u1ea5y t\u1edd t\u00f9y th\u00e2n \u0111\u1ec3 m\u1edf t\u00e0i kho\u1ea3n nhanh ch\u00f3ng<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>N\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;PCVX&#8221;<\/td>\n<td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ecm &#8220;Vaxcyte&#8221;<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n<\/td>\n<td>\u0110\u1eb7t gi\u00e1 mua t\u1ed1i \u0111a \u0111\u1ec3 tr\u00e1nh tr\u1ea3 qu\u00e1 cao<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Ki\u1ec3m tra chi ti\u1ebft l\u1ec7nh<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng \u2014 n\u00ean d\u01b0\u1edbi 1%<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>X\u00e1c nh\u1eadn mua<\/td>\n<td>B\u1ea1n \u0111\u00e3 s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n c\u00f4ng ty vaccine s\u00e1ng t\u1ea1o<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/td>\n<td>Nh\u1eadn th\u00f4ng b\u00e1o khi c\u00f3 bi\u1ebfn \u0111\u1ed9ng gi\u00e1 l\u1edbn<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Theo d\u00f5i tin t\u1ee9c<\/td>\n<td>Theo d\u00f5i c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 quy\u1ebft \u0111\u1ecbnh FDA<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u0110\u00e1nh gi\u00e1 \u0111\u1ecbnh k\u1ef3<\/td>\n<td>C\u00f4ng ngh\u1ec7 sinh h\u1ecdc c\u1ea7n theo d\u00f5i t\u00edch c\u1ef1c, kh\u00f4ng ph\u1ea3i mua r\u1ed3i qu\u00ean<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf khi giao d\u1ecbch c\u1ed5 phi\u1ebfu nh\u01b0 PCVX:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> \u2014 ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li>\n<li><strong>Quy tr\u00ecnh KYC 1 ph\u00fat<\/strong> \u2014 t\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch ngay<\/li>\n<li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> \u2014 t\u1eeb ti\u1ec1n \u0111i\u1ec7n t\u1eed \u0111\u1ebfn v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 th\u1ebb ng\u00e2n h\u00e0ng<\/li>\n<li><strong>C\u1ed5 phi\u1ebfu l\u1ebb c\u00f3 s\u1eb5n<\/strong> \u2014 mua ph\u1ea7n nh\u1ecf c\u1ee7a c\u00e1c c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n nh\u01b0 PCVX m\u00e0 kh\u00f4ng c\u1ea7n mua nguy\u00ean c\u1ed5 phi\u1ebfu<\/li>\n<\/ul>\n<p>N\u1ec1n t\u1ea3ng v\u1edbi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p n\u00e0y r\u1ea5t l\u00fd t\u01b0\u1edfng cho ng\u01b0\u1eddi m\u1edbi mu\u1ed1n ti\u1ebfp c\u1eadn c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u1ec1m n\u0103ng cao m\u00e0 kh\u00f4ng c\u1ea7n \u0111\u1ea7u t\u01b0 s\u1ed1 v\u1ed1n l\u1edbn.<\/p>\n<h2>\ud83c\udf0d Vaxcyte N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi Vaccine<\/h2>\n<p>Vaxcyte \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong c\u00f4ng ngh\u1ec7 vaccine th\u1ebf h\u1ec7 m\u1edbi. S\u1eed d\u1ee5ng n\u1ec1n t\u1ea3ng \u0111\u1ed9c quy\u1ec1n XpressCF\u2122, h\u1ecd \u0111ang ph\u00e1t tri\u1ec3n c\u00e1c vaccine li\u00ean h\u1ee3p c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta ph\u00f2ng ng\u1eeba c\u00e1c b\u1ec7nh nhi\u1ec5m khu\u1ea9n <a href=\"https:\/\/stockanalysis.com\/stocks\/pcvx\/company\/\">StockAnalysis<\/a>.<\/p>\n<p>\u1ee8ng vi\u00ean h\u00e0ng \u0111\u1ea7u c\u1ee7a c\u00f4ng ty, VAX-24, nh\u1eafm v\u00e0o 24 ch\u1ee7ng vi khu\u1ea9n ph\u1ebf c\u1ea7u, trong khi VAX-31 m\u1edf r\u1ed9ng l\u00ean 31 ch\u1ee7ng \u2014 c\u00f3 th\u1ec3 cung c\u1ea5p s\u1ef1 b\u1ea3o v\u1ec7 r\u1ed9ng h\u01a1n vaccine hi\u1ec7n c\u00f3. V\u1edbi 414 nh\u00e2n vi\u00ean v\u00e0 tr\u1ee5 s\u1edf t\u1ea1i San Carlos, California, Vaxcyte \u0111\u1ea1i di\u1ec7n cho s\u1ef1 \u0111\u1ed5i m\u1edbi c\u1ee7a n\u01b0\u1edbc M\u1ef9 \u1edf m\u1ee9c cao nh\u1ea5t.<\/p>\n<p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb<\/strong>: N\u0103m 2025, ch\u1ec9 \u0111\u1ecbnh \u0110i\u1ec1u Tr\u1ecb \u0110\u1ed9t Ph\u00e1 c\u1ee7a FDA d\u00e0nh cho Vaxcyte \u0111\u00e3 \u0111\u01b0\u1ee3c m\u1edf r\u1ed9ng bao g\u1ed3m ph\u00f2ng ng\u1eeba vi\u00eam ph\u1ed5i \u2014 m\u1ed9t th\u00e0nh t\u1ef1u quy \u0111\u1ecbnh hi\u1ebfm c\u00f3 l\u00e0m n\u1ed5i b\u1eadt t\u1ea7m quan tr\u1ecdng ti\u1ec1m n\u0103ng c\u1ee7a \u1ee9ng vi\u00ean vaccine VAX-31 <a href=\"https:\/\/www.stocktitan.net\/news\/PCVX\/vaxcyte-reports-second-quarter-2025-financial-results-and-provides-9l3y1y5unk80.html\">StockTitan<\/a>. \u0110i\u1ec1u n\u00e0y \u0111\u1eb7t h\u1ecd v\u00e0o nh\u00f3m tinh hoa trong s\u1ed1 c\u00e1c nh\u00e0 \u0111\u1ed5i m\u1edbi c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu NASDAQ, ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 PCVX, \u0111\u1eb7t l\u1ec7nh mua v\u1edbi gi\u00e1 gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i giao d\u1ecbch c\u1ee7a b\u1ea1n."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o Vaxcyte l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, s\u1ef1 kh\u00f4ng ch\u1eafc ch\u1eafn v\u1ec1 quy \u0111\u1ecbnh, ti\u00eau ti\u1ec1n m\u1eb7t l\u1edbn v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty vaccine l\u1edbn nh\u01b0 Pfizer."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1 c\u1ee7a c\u1ed5 phi\u1ebfu PCVX trong t\u01b0\u01a1ng lai ra sao?","answer":"C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean 40-50 USD v\u00e0o cu\u1ed1i n\u0103m 2025 v\u00e0 l\u00ean t\u1edbi 180-220 USD v\u00e0o n\u0103m 2030, v\u1edbi m\u1ee9c t\u0103ng trung b\u00ecnh kho\u1ea3ng 343% so v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 PCVX?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh KYC nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 h\u1ed7 tr\u1ee3 mua c\u1ed5 phi\u1ebfu l\u1ebb, r\u1ea5t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi."},{"question":"Vaxcyte c\u00f3 \u0111i\u1ec3m g\u00ec n\u1ed5i b\u1eadt trong l\u0129nh v\u1ef1c vaccine?","answer":"Vaxcyte s\u1eed d\u1ee5ng n\u1ec1n t\u1ea3ng XpressCF\u2122 \u0111\u1ec3 ph\u00e1t tri\u1ec3n vaccine li\u00ean h\u1ee3p v\u1edbi \u1ee9ng vi\u00ean VAX-31 nh\u1eafm \u0111\u1ebfn 31 ch\u1ee7ng vi khu\u1ea9n, \u0111\u01b0\u1ee3c FDA ch\u1ec9 \u0111\u1ecbnh \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 m\u1edf r\u1ed9ng cho ph\u00f2ng ng\u1eeba vi\u00eam ph\u1ed5i."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu NASDAQ, ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 PCVX, \u0111\u1eb7t l\u1ec7nh mua v\u1edbi gi\u00e1 gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i giao d\u1ecbch c\u1ee7a b\u1ea1n."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o Vaxcyte l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, s\u1ef1 kh\u00f4ng ch\u1eafc ch\u1eafn v\u1ec1 quy \u0111\u1ecbnh, ti\u00eau ti\u1ec1n m\u1eb7t l\u1edbn v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty vaccine l\u1edbn nh\u01b0 Pfizer."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1 c\u1ee7a c\u1ed5 phi\u1ebfu PCVX trong t\u01b0\u01a1ng lai ra sao?","answer":"C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean 40-50 USD v\u00e0o cu\u1ed1i n\u0103m 2025 v\u00e0 l\u00ean t\u1edbi 180-220 USD v\u00e0o n\u0103m 2030, v\u1edbi m\u1ee9c t\u0103ng trung b\u00ecnh kho\u1ea3ng 343% so v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 PCVX?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh KYC nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 h\u1ed7 tr\u1ee3 mua c\u1ed5 phi\u1ebfu l\u1ebb, r\u1ea5t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi."},{"question":"Vaxcyte c\u00f3 \u0111i\u1ec3m g\u00ec n\u1ed5i b\u1eadt trong l\u0129nh v\u1ef1c vaccine?","answer":"Vaxcyte s\u1eed d\u1ee5ng n\u1ec1n t\u1ea3ng XpressCF\u2122 \u0111\u1ec3 ph\u00e1t tri\u1ec3n vaccine li\u00ean h\u1ee3p v\u1edbi \u1ee9ng vi\u00ean VAX-31 nh\u1eafm \u0111\u1ebfn 31 ch\u1ee7ng vi khu\u1ea9n, \u0111\u01b0\u1ee3c FDA ch\u1ec9 \u0111\u1ecbnh \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 m\u1edf r\u1ed9ng cho ph\u00f2ng ng\u1eeba vi\u00eam ph\u1ed5i."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T06:15:55+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)\",\"datePublished\":\"2025-08-29T06:15:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-29T06:15:55+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T06:15:55+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)","datePublished":"2025-08-29T06:15:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-29T06:15:55+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-vaxcyte\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Vaxcyte, Inc. (PCVX)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":356328,"slug":"how-to-buy-vaxcyte","post_title":"Como comprar a\u00e7\u00f5es da Vaxcyte, Inc. (PCVX) - Investimento em a\u00e7\u00f5es da Vaxcyte, Inc. (PCVX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-vaxcyte\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/356331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=356331"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/356331\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=356331"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=356331"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=356331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}